Overview
Linda Van Der Graaf practices in Leiden, Netherlands. Ms. Van Der Graaf is rated as an Experienced expert by MediFind in the treatment of Prostate Cancer. Her top areas of expertise are Hereditary Cerebral Amyloid Angiopathy, Cerebral Amyloid Angiopathy, Spinocerebellar Ataxia Type 1, and Primary Amyloidosis.
Her clinical research consists of co-authoring 21 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Locations
Leiden, ZH, Netherlands
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Cerebral Amyloid AngiopathyMs. Van Der Graaf isAdvanced. Learn about Cerebral Amyloid Angiopathy.
- Hereditary Cerebral Amyloid AngiopathyMs. Van Der Graaf isAdvanced. Learn about Hereditary Cerebral Amyloid Angiopathy.
- Spinocerebellar Ataxia Type 1Ms. Van Der Graaf isAdvanced. Learn about Spinocerebellar Ataxia Type 1.
- Experienced
- Alzheimer's DiseaseMs. Van Der Graaf isExperienced. Learn about Alzheimer's Disease.
- CalcinosisMs. Van Der Graaf isExperienced. Learn about Calcinosis.
- DementiaMs. Van Der Graaf isExperienced. Learn about Dementia.
- Drug Induced DyskinesiaMs. Van Der Graaf isExperienced. Learn about Drug Induced Dyskinesia.
- Huntington DiseaseMs. Van Der Graaf isExperienced. Learn about Huntington Disease.
- Olivopontocerebellar AtrophyMs. Van Der Graaf isExperienced. Learn about Olivopontocerebellar Atrophy.